Perspectives in Breast Cancer Pathology
by Michael Lagios, MD

     

 

       Please click on title to view complete text:

 

Contradictory Treatment Recommendations for Ductal Carcinoma in situ (DCIS).

​

Risk of DCIS Recurrence by Oncotype DCIS Technology - Some Concerns.

​

The Clinical Significance of immunohistochemically Detectable Epithelial Cells in Sentinel Lymph Node and Bone Marrow in Breast Cancer.

​

Factors Influencing the Accuracy of a Core Biopsy Diagnosis of Atypical Hyperplasia.  A Perspective on a Frequent Pattern.

​

Tamoxifen as an Adjuvant Agent for Ductal Carcinoma In Situ (DCIS)

  • Home

  • Second Opinion Service

  • About

  • CV

  • Publications

  • Perspectives

  • Referral Process

  • Contact

  • More

    Use tab to navigate through the menu items.

    The Breast Cancer Consultation Service

    Michael D. Lagios, MD   •   415-789-0965

    The Breast Cancer Consultation Service
    PO Box 950, Tiburon, CA  94920
    415-789-0965
    Please read Terms of Service